BIOVOX
Darmstadt
About BIOVOX
BIOVOX is the sustainable healthcareFuture-proof your polymers with BIOVOX biobased and recyclable plastics in Medical Grade quality. Developed for healthcare, they are ideal for the production of medical devices and sterile barrier packaging. They are free from critical substances such as PFAS and BPA, and have up to 85% lower carbon emissions than conventional medical grade plastics. BIOVOX bioplastics are manufactured under an ISO 13485-certified quality management system and have been successfully tested for biological safety in accordance with ISO 10993. As the healthcare sector faces growing pressure to eliminate critical substances and reduce carbon emissions, a paradigm shift in material choice is inevitable. By choosing BIOVOX bioplastics, you can reduce carbon emissions, prepare for upcoming regulations, and gain a competitive edge. The healthcare market demands competitive pricing, secure supply chains, and stable formulations’BIOVOX delivers on all three. With EU regulations driving sustainability and the industry already moving toward circularity, BIOVOX plastics are the safer choice’and there’s no better time to innovate than now. Let’s partner up and future-proof your products! market, setting the standard for bioplastic compounds made from renewable resources.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $2.4M
- Funding stage: Seed
- Last round: Seed (Sep 2024)
- Website: biovox.systems
- Phone: +49 6151 7869330
Industries & Categories
Advanced Materials, Medical, Medical Device, Pharmaceutical, Plastics and Rubber Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/biovox-47482 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.